Citi lowered the firm’s price target on Healthpeak Properties (DOC) to $17.50 from $18 and keeps a Neutral rating on the shares. Citi also opened an “upside 30-day catalyst watch” on Healthpeak. The firm sees the Janus Living initial public offering as highlighting the stock’s “valuation gap.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties Expands Credit Facilities to Enhance Liquidity
- Opening Day: Janus Living opens at $23.50 after upsized IPO
- Janus Living opens at $23.50, IPO priced at $20 per share
- Janus Living indicated to open at $23.50-$24, IPO priced at $20 per share
- Janus Living indicated to open at $23-$24, IPO priced at $20 per share